Real-world effectiveness and safety of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes and renal impairment: a subgroup analysis of the ATOS study

被引：0

作者：

Tirosh, A. ^{[1
,2
]}

Khan, N. ^{[3
]}

Vargas-Uricoechea, H.

Mabunay, M. A. N. ^{[4
]}

Coudert, M. ^{[5
]}

Pilorget, V. ^{[5
]}

Galstyan, G. ^{[6
]}

机构：

[1] Chaim Sheba Med Ctr, Div Endocrinol Diabet & Metab, Tel Hashomer, Israel

[2] Tel Aviv Univ, Tel Hashomer, Israel

[3] Imperial Coll London, Diabet Ctr, Al Ain, U Arab Emirates

[4] Univ Cauca, Div Endocrinol & Metab, Dept Internal Med, Popayan Cauca, Colombia

[5] Sanofi, Singapore, Singapore

[6] Hlth Care Minist Russian Federat, Endocrinol Res Ctr, Moscow, Russia

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

506

引用

页码：264 / 265

页数：2